Meet our leadership team and executive management
President and Chief Executive Officer
Guido Baechler was appointed President and Chief Executive Officer of Singulex in May 2013. Mr. Baechler has worked with emerging technologies in the life sciences and the diagnostics industries for more than two decades, including serving in leadership positions at Roche, and, since 2010, as Senior Vice President of Operations at Singulex. Prior to 2010, Mr. Baechler served as Singulex’s Vice President of Diagnostics from 2008 until 2009. From 1989 until 2008, Mr. Baechler held leadership positions at Roche Diagnostics and Roche Molecular Diagnostics, or RMD, in both Switzerland and the United States, within research, development, marketing and executive management. Mr. Baechler holds a bachelor’s degree in Electrical Engineering from Fachhochschule Brugg-Windisch in Switzerland. He also completed a series of executive finance and management classes at the London School of Business and at the Haas Business School in Berkeley.
Chief Financial Officer
Mike Bell has served as our Chief Financial Officer since May of 2012. As a finance professional, Mr. Bell has more than 18 years of international experience gained from a range of strategic, commercial and operational finance positions. From 2008 to 2012, Mr. Bell held finance positions at Novartis Diagnostics and, prior to joining us, served as Global Head of Finance where he was a member of the Diagnostics Leadership Team and had overall responsibility for finance and accounting across the worldwide business. From 2006 to 2008, Mr. Bell served as Finance Head for the Asia Pacific, Middle East, and Africa regions for Novartis Vaccines where he focused on commercial finance strategies and operations in emerging markets. Prior to this, Mr. Bell was a Finance Director of Chiron Corporation, a multinational biotechnology firm. Before joining the healthcare industry, Mr. Bell spent a combined 10 years in public accounting with firms Ernst & Young and Deloitte where he led a wide range of audit and consulting engagements. Mr. Bell is a Fellow of the Institute of Chartered Accountants in England & Wales and received a bachelor’s degree in Mathematics with Computing from the University of Leicester in the United Kingdom.
F. Steven Feinberg
Senior Vice President, Sales and Marketing and Chief Commercial Officer
Steve Feinberg has served as our Senior Vice President of Sales and Marketing and our Chief Commercial Officer since October 2011 and has more than 30 years of experience in the healthcare industry. Prior to joining us, from 2008 until 2011, Mr. Feinberg was the Vice President and Zone General Manager for Siemens Healthcare, an international supplier of diagnostic and therapeutic equipment where he was responsible for the healthcare business in the western zone of the United States. From 2006 to 2008, Mr. Feinberg served as President and Chief Executive Officer of Siemens Asahi Medical Technologies in Japan, and, from 2001 until 2006, he served as President of Siemens China Medical Solutions Group and was appointed Executive Vice President and a member of the Management Board for Siemens China. From 2003 until 2006, Mr. Feinberg served as member of the boards of directors of several subsidiaries of Siemens AG. Prior to joining Siemens, Mr. Feinberg held various senior management positions for medical device companies such as Acuson Corporation, Diasonics, Inc., and Medtronic, Inc. Mr. Feinberg holds a bachelor’s degree in Biological Sciences from the University of California, Davis and a Nuclear Medicine Technology Diploma from the University of Southern California.
Vice President, Business Development
Linda Greub has served as our Vice President, Business Development since June 2013, bringing with her over 25 years of business development, strategy and investment experience in the healthcare and financial services industries. Ms. Greub joined Singulex from Novartis Diagnostics where she served as Global Director, Strategy and Business Development. Her previous healthcare experience includes serving as Senior Director, Strategy and Business Development at Applied Biosystems (Life Technologies), with primary responsibility for mergers & acquisitions. Before joining the healthcare industry, Ms. Greub worked as a senior healthcare analyst for investment banks and hedge funds, including Banc of America Securities, Tudor Investment Corporation and Essex Investment Management. Ms. Greub is a Chartered Financial Analyst. She holds a B.A. from Yale University and an M.B.A. from the Harvard Business School.
Jeffrey J. Bishop, Ph.D.
Vice President, Research and Development
Jeff Bishop joined Singulex in September 2013 as our Vice President of Research and Development. Dr. Bishop has worked in the diagnostics industry for over 13 years, holding various leadership positions within the R&D organization at Biosite Diagnostics (later Inverness Medical Innovations and Alere, Inc.) where he led the development of many point-of-care assays across a wide range of disease states. Dr. Bishop holds a B.S. degree in Chemical Engineering from Brigham Young University as well as M.S. and Ph.D. degrees in Bioengineering from the University of California, San Diego.
Vice President, Human Resources
Bill Hammack comes to Singulex with nearly 40 years of experience in the human resources field, primarily with technology companies. He has provided service to companies sized from a few hundred employees to tens of thousands with operations around the world. His background includes creating and managing human resources departments and programs for start-up companies as well as managing HR activities for multi-national public organizations. He has worked in Europe, Asia and the Middle East. Mr. Hammack has been a Vice President of HR for more than 30 years serving such companies as Silicone Image, Komag Inc., General Electric Medical Systems and Diasonics/Elbit Medical Systems. He holds a B.A. in Public Policy/Administration from San Diego State University.